These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 10742837

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [The treatment of localized cancer of the prostate using radioactive iodine implants].
    Fradet Y, Laverdière J, Beaudoin L.
    Union Med Can; 1985 Sep; 114(9):737-9. PubMed ID: 4060345
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F, Multicentric Spanish Group of Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):421-32. PubMed ID: 18325680
    [Abstract] [Full Text] [Related]

  • 29. [Brachytherapy in the curative treatment of localized prostatic cancer].
    Flam T, Chauveinc L, Servois V, Rosenwald JC, Cosset JM, Thiounn N, Debré B.
    Prog Urol; 2000 Feb 01; 10(1):3-13. PubMed ID: 10785912
    [Abstract] [Full Text] [Related]

  • 30. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
    Klein EA, Ciezki J, Kupelian PA, Mahadevan A.
    Urol Oncol; 2009 Feb 01; 27(1):67-71. PubMed ID: 19111801
    [Abstract] [Full Text] [Related]

  • 31. A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy.
    Ciezki JP, Klein EA, Angermeier K, Ulchaker J, Chehade N, Altman A, Mahadevan A, Reddy CA.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1347-50. PubMed ID: 15590163
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Analysis of iodine-125 interstitial therapy in the treatment of localized carcinoma of the prostate.
    Gomella LG, Steinberg SM, Ellison MF, Reeves WW, Flanigan RC, McRoberts JW.
    J Surg Oncol; 1991 Apr 01; 46(4):235-40. PubMed ID: 2008089
    [Abstract] [Full Text] [Related]

  • 36. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
    Copeland LA, Elshaikh MA, Jackson J, Penner LA, Underwood W.
    Cancer; 2005 Oct 01; 104(7):1372-80. PubMed ID: 16118801
    [Abstract] [Full Text] [Related]

  • 37. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer.
    Langley SE, Laing RW.
    Prostate Cancer Prostatic Dis; 2004 Oct 01; 7(3):201-7. PubMed ID: 15184864
    [Abstract] [Full Text] [Related]

  • 38. Brachytherapy and teletherapy for carcinoma of the prostate. University of Missouri-Columbia protocol.
    Abadir R, Ross G, Weinstein SH.
    Mo Med; 1983 Apr 01; 80(4):194-6. PubMed ID: 6855744
    [No Abstract] [Full Text] [Related]

  • 39. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach.
    Salomon L, Levrel O, Anastasiadis AG, Saint F, de La Taille A, Cicco A, Vordos D, Hoznek A, Chopin D, Abbou CC.
    Prostate Cancer Prostatic Dis; 2002 Apr 01; 5(4):285-90. PubMed ID: 12627213
    [Abstract] [Full Text] [Related]

  • 40. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Albertsen PC.
    J Urol; 2005 Nov 01; 174(5):1969-70. PubMed ID: 16217368
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.